Brain Diseases: all 763 studies

Page 7 of 8. Open to participants first (203), then studies with results posted, then the rest; newest registration first within each.

• Brain Activity During Birth for Prediction of Newborns at Risk for Brain InjuryCompletedNCT02445417
• Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)CompletedNCT02444091Phase 2
• Neurological Outcome in Surgical and Non-surgical Septic PatientsCompletedNCT02442986
• Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal BacterialTerminatedNCT02439307Not applicable
• Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic EncephalopathyWithdrawnNCT02434965Phase 2
• A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure DetectionCompletedNCT02431780Not applicable
• Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic PatientsStatus unknownNCT02427906
• High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic EncephalopathyTerminatedNCT02418039Not applicable
• Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic EncephalopathyStatus unknownNCT02401490Phase 4
• Hypothermia for Encephalopathy in Low and Middle-Income Countries TrialCompletedNCT02387385Not applicable
• Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)CompletedNCT02349672
• The Effects of Nitazoxanide in Hepatic EncephalopathyStatus unknownNCT02334163Phase 2
• A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected PatientsCompletedNCT02291081
• Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated EncephalopathyCompletedNCT02288715
• Umbilical Cord Milking for Neonates With Hypoxic Ischemic EncephalopathyCompletedNCT02287077Not applicable
• Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain InjuryCompletedNCT02266563
• Developmental OutcomesCompletedNCT02264808
• Autologous Cord Blood Cell Therapy for Neonatal EncephalopathyCompletedNCT02256618Phase 1
• Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot StudyCompletedNCT02255617Phase 1/2
• Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic EncephalopathiesNo longer availableNCT02239276
• Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel DiseaseTerminatedNCT02232958Not applicable
• Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac ArrestCompletedNCT02231060
• B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.CompletedNCT02229942Phase 3
• PET Imaging in Chronic Traumatic EncephalopathyCompletedNCT02211820
• Quantitative Determination of Brain Water Content in Patients During and After Hepatic EncepalopathyStatus unknownNCT02177708
• Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal BleedingCompletedNCT02158182Phase 4
• Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic EncephalopathyCompletedNCT02156232Not applicable
• iPod Games in Hepatic EncephalopathyCompletedNCT02154282Not applicable
• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
• A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal FailureWithdrawnNCT02086825Phase 3
• Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy OutcomeCompletedNCT02083367
• Transcranial Stimulation (tDCS) and Prism Adaptation in Spatial Neglect RehabilitationStatus unknownNCT02080286Not applicable
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at BirthCompletedNCT02071394Phase 2
• TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary ResuscitationCompletedNCT02056236Not applicable
• Study on Moebius Syndrome and Congenital Facial Weakness DisordersCompletedNCT02055248
• NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic EncephalopathyCompletedNCT02051894
• Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRSWithdrawnNCT02048969Phase 1/2
• Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.Status unknownNCT02028429Phase 1/2
• Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)TerminatedNCT02026609
• Fructans, Lactitol and Lactose in Minimal Hepatic EncephalopathyCompletedNCT02022137Not applicable
• Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic EncephalopathyCompletedNCT02019784Phase 4
• BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.CompletedNCT02019147
• Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic PatientsCompletedNCT02017119Phase 2
• Neurofeedback Using TMS as an Assessment ToolStatus unknownNCT01993316Not applicable
• Natural History Study of Children With Metachromatic LeukodystrophyTerminatedNCT01963650
• Protein Supplementation in Infants With Brain InjuryCompletedNCT01936246Not applicable
• Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)WithdrawnNCT01923376Not applicable
• The Neurological Pupil Index (NPi) on Intensive Care Unit (ICU) TrialCompletedNCT01920347
• Determining Optimal Post-Stroke Exercise (DOSE)CompletedNCT01915368Not applicable
• Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic EncephalopathyWithdrawnNCT01904786Phase 1
• Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military PersonnelWithdrawnNCT01891383
• Effect of Music on Attention and Prospective Memory in Hepatic EncephalopathyWithdrawnNCT01882855
• Neuromonitoring of Hepatic EncephalopathyCompletedNCT01878305
• Vascular Risk Factors in INPH-patientsCompletedNCT01850914
• Factors Associated With End Stage Liver DiseaseTerminatedNCT01846819
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.TerminatedNCT01846806Not applicable
• Quality of Life and Nutritional Improvements in Cirrhotic PatientsTerminatedNCT01842113Phase 4
• ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional StudyStatus unknownNCT01798329Phase 3
• Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time MeasurementCompletedNCT01773538Not applicable
• Hypothermia for Encephalopathy in Low Income Countries-FeasibiltyCompletedNCT01760629Not applicable
• L-ornithine L-aspartate in Overt Hepatic EncephalopathyCompletedNCT01722578Phase 4
• Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic PainStatus unknownNCT01699477Phase 1
• The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-ADStatus unknownNCT01696591
• Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's DiseaseCompletedNCT01662414Phase 4
• Autologous Cord Blood Cells for Brain Injury in Term NewbornsCompletedNCT01649648Phase 1
• Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic EncephalopathyStatus unknownNCT01646619Phase 3
• Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young InfantsCompletedNCT01624311Phase 2
• Bioelectrical Impedance Vector Analysis in Cirrhotic PatientsCompletedNCT01603953
• Cerebrovascular Autoregulation During and After Liver TransplantationStatus unknownNCT01597102
• Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic EncephalopathyCompletedNCT01559519Phase 4
• Effect of Tolvaptan on Cognitive Function in CirrhosisCompletedNCT01556646Phase 3
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at BirthCompletedNCT01545271Phase 1/2
• The Natural History of Procalcitonin in Hemorrhagic StrokeWithdrawnNCT01498705
• Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive CareCompletedNCT01494064
• Epidemiological, Clinical and Etiological Features of SUSAC's SyndromeStatus unknownNCT01481662
• Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic EncephalopathyCompletedNCT01481207
• S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHECompletedNCT01446523Not applicable
• Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance ImagingStatus unknownNCT01434056
• Autoregulation Assessment During Liver TransplantationCompletedNCT01425385
• Transcranial Stimulation and Motor Training in Stroke RehabilitationStatus unknownNCT01414582Phase 2/3
• Influence of Physical Exercise on Cognitive Functioning of Traumatic Brain Injury PatientsStatus unknownNCT01395472Not applicable
• Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in CirrhoticsStatus unknownNCT01356121Phase 4
• A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
• Magnetic Resonance Biomarkers in Neonatal EncephalopathyCompletedNCT01309711
• Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With HypothermiaCompletedNCT01241019Phase 2
• Acetyl-L-Carnitine In Severe Hepatic EncephalopathyCompletedNCT01223768Not applicable
• Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic EncephalopathyCompletedNCT01223742Not applicable
• Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic EncephalopathyCompletedNCT01223729Not applicable
• Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized TrialCompletedNCT01218568Not applicable
• Connectivity Analysis for Investigation of Auditory Impairment in EpilepsyTerminatedNCT01212068
• Secondary Prophylaxis of Hepatic Encephalopathy in CirrhosisStatus unknownNCT01178372Phase 4
• Primary Prophylaxis of Hepatic Encephalopathy in Patients With CirrhosisStatus unknownNCT01175538Phase 4
• Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)CompletedNCT01151475
• Whole Body Cooling Using Phase Changing MaterialStatus unknownNCT01138176Phase 1/2
• MRI Thermal Imaging of Infants Undergoing Cooling for Hypoxic Ischemic Encephalopathy(HIE)WithdrawnNCT01128673
• Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic EncephalopathyTerminatedNCT01113567Not applicable
• Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic PreparationCompletedNCT01110447Phase 2/3
• Cerebrovascular Reactivity in Hepatic EncephalopathyCompletedNCT01099293
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic EncephalopathyStatus unknownNCT01097811Not applicable
• Sedation to Electroencephalography With Dexmedetomidine or Chloral HydrateCompletedNCT01083797Phase 3

← Brain Diseases overview